{"public_id":"cl_dfd7942035a9e74a632ac195d5e32c6d","status":"active","superseded_by_public_id":null,"corpus_id":220056928,"text":"MOG-antibody disease comprises a significant proportion of aquaporin 4-antibody-seronegative neuromyelitis optica spectrum disorder cases, and its annual incidence in a Dutch nationwide study was 1.6 per million population.","confidence":0.93,"paper":{"corpus_id":220056928,"title":"Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence Worldwide","url":"https://sah.borca.ai/papers/220056928"},"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.93,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_484cbeb16358949548c08662dea3e882","name":"MOG-antibody disease","description":"A myelin oligodendrocyte glycoprotein-antibody-positive inflammatory demyelinating disease included among cases clinically diagnosed as neuromyelitis optica spectrum disorder.","types":["disease subtype"],"url":"https://sah.borca.ai/concepts/co_484cbeb16358949548c08662dea3e882"},{"public_id":"co_4d2684e74a0c22cd073ae579b55e008c","name":"aquaporin 4-antibody-seronegative neuromyelitis optica spectrum disorder","description":"Neuromyelitis optica spectrum disorder cases that do not show aquaporin 4 antibody seropositivity.","types":["disease subgroup"],"url":"https://sah.borca.ai/concepts/co_4d2684e74a0c22cd073ae579b55e008c"},{"public_id":"co_9d73322f27fbe1756a2197a9269b5b6a","name":"incidence","description":"The rate at which new cases occur in a population over time.","types":["epidemiologic measure"],"url":"https://sah.borca.ai/concepts/co_9d73322f27fbe1756a2197a9269b5b6a"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_dfd7942035a9e74a632ac195d5e32c6d"}